atos stock price target 2021

Q2 GAAP EPS of -005. View analysts price targets for ATOS or view top-rated stocks among Wall Street analysts.


Updating On Yara International Otcmkts Yariy Seeking Alpha

1y Target Est 1394 Fair Value is the appropriate price for the shares of a company based on its earnings and growth rate also interpreted as when PE Ratio Growth Rate.

. 1179 Average target price. Atossa Therapeutics press release NASDAQATOS. See more on advanced chart.

900 Spread Lowest Target-236. Their ATOS share price forecasts range from 700 to 700. Atossa Therapeutics - ATOS Price Target Analyst Ratings.

Total operating expenses were 6595 for the three months ended June 30 2022 which is a decrease of 409 or 6 from the three months ended June 30 2021 of 7004. Fair Value is the appropriate. Atossa Therapeutics current and average target prices are 114 and 700 respectively.

The price target was set to 800. Those same analysts give the stock an average rating of Strong Buy. 10 2021 at 755 am.

On average they anticipate the companys share price to reach 700 in the next twelve months. 1425 Spread Average Target. Stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy.

Based on analysts offering 12 month price targets for ATOS in the last 3 months. See Atossa Therapeutics Inc. On average analysts rate ATOS stock as a buy.

1028 Average target price. The current price of Atossa Therapeutics is the price at which Atossa Therapeutics is currently trading. Markets Mexico Stocks Health Technology Pharmaceuticals.

Price Target Last Issued June 25 2021. Earnings Forecast for Atossa Therapeutics Inc Stock NASDAQATOS According to 2 analysts the average EPS forecast for Atossa Therapeutics Inc stock for June 30 2021 is -003 with a low forecast at -004 and a high forecast at -003 Revenue Forecast for ATOS Stock. Company had cash cash equivalents and restricted cash of approximately 125647.

High Price Target. Last Close Price. Stock Price Forecast.

Price Target Last Issued June 25 2021. This suggests a possible upside of 6295 from the stocks current price. Atossa Therapeutics prices 25M direct offering stock -23 PM Seeking Alpha Jan 06 2021 Atossa Therapeutics prices 14M registered direct offering Seeking Alpha Dec â Learn more.

Stock Price Forecast The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 550 with a high estimate of 700 and a low estimate of 400. On the other hand Atossa Therapeutics target price is what analysts think the stock is worth or could sell for in the future. Atossa Therapeutics stock price target raised to 7 from 5 at Maxim Group.

Forward Dividend Yield. Get the latest Atos SE ATO real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. ATOSs average price target has moved up 025 over the prior 65 days.

ATOSs average price target has moved up 025 over the prior 65 days. The Trend in the Analyst Price Target. 2600 Spread Highest target.

1469 Spread Average Target. ATOS reports an average of 11254 for its upside potential over the past 170 days. The Trend in the Analyst Price Target.

NA NA Ex-Dividend Date. 000 000 As of 08262022 1200 AM ET Todays Range. ET by Tomi Kilgore.

ATOS Stock Forecast Price Target for 2023 TradingView. The lowest target is 404 and the highest is 788. Nov 14 2022 - Nov 18 2022.

According to 8 stock analysts the average 12-month stock price forecast for ATOS stock is 587 which predicts an increase of 487. According to 8 analysts the average rating for ATOS stock is Buy The 12-month stock price forecast is 587 which is an increase of 48700 from the latest price. Last Close Price.

Wednesday January 20 2021 0123 PM InvestorsObserver Analysts Analysts who follow Atossa Therapeutics Inc ATOS on average expect it to gain 30816 over the next twelve months.


Atos An Eu Investment With A High Upside Otcmkts Aexaf Seeking Alpha


Live Markets U S Cpi What About Dollar And Bonds Reuters


Ringcentral Stock Cut In Half Making It A Screaming Buy Nyse Rng Seeking Alpha


Atossa S Nasal Spray Candidate Could Yet Join The Fight Against Covid 19


Ringcentral Stock Cut In Half Making It A Screaming Buy Nyse Rng Seeking Alpha


Live Markets U S Cpi What About Dollar And Bonds Reuters


Why Atossa Therapeutics Soared 20 Higher Today The Motley Fool


Ringcentral Stock Undervalued By More Than 90 Nyse Rng Seeking Alpha


Worldline On Its Way To 3 Eur Share In Free Cash Flow In 2024 Seeking Alpha


Atossa S Covid 19 Treatment Has Potential Says Analyst


Why Atossa Therapeutics Soared 20 Higher Today The Motley Fool


Enterprise Unified Communication And Voice Equipment Market Tracker 3q21 Analysis Omdia


Live Markets U S Cpi What About Dollar And Bonds Reuters


Enterprise Unified Communication And Voice Equipment Market Tracker 3q21 Analysis Omdia


Annual Report For The Gps Funds I


Atos An Eu Investment With A High Upside Otcmkts Aexaf Seeking Alpha


Atos An Eu Investment With A High Upside Otcmkts Aexaf Seeking Alpha


Enterprise Unified Communication And Voice Equipment Market Tracker 3q21 Analysis Omdia


Best Penny Stocks For August 2022 Based On Technical Analysis

Iklan Atas Artikel

Iklan Tengah Artikel 1